Advanced Therapies Congress presents:

CAR-T day

 
Thursday 18th March | 3pm-5pm GMT
 

 

 

CONFIRMED SPEAKERS

 
 
 
 

PANEL DISCUSSION: TACKLING SOLID TUMOURS

3pm-4pm GMT

 

Novel strategies for overcoming hurdles to solid tumor gene modified cell therapy will be discussed

 

 

 

• Hurdles to solid tumor cell therapy and novel strategies to overcome

• Autologous and allogeneic cell therapy for solid tumors

• Potential role for combination cellular therapies

 

 

 

Emanuele Ostuni , Head of Europe, Cell & Gene Therapy, Novartis (confirmed)

Prasad Adusumilli , Attending Surgeon, Memorial Sloan Kettering Cancer Center (confirmed)

Steve Kanner , CSO, Caribou Biosciences (confirmed)

 

BOOK FREE TICKETS

 

PANEL DISCUSSION: AUTOLOGOUS VS ALLOGENEIC

4pm-5pm GMT

 

 

PANEL: Autologous vs Allogeneic: Identify the challenges and opportunities for cost teffective and efficacious therapies

 

 

• Rise of allogeneic cells and allo-approaches to oncology & non-oncology

• Tools and technologies to make this a reality

 

 

 

Chair: Albert Ribickas , Bone Marrow Transplant Laboratory Manager, Moffitt Cancer Center (confirmed)

Stefanos Theoharis , CBO , Bone Therapeutics (confirmed)

Jakob Dupont , Global Head of R&D, Atara Biotherapeutics (confirmed)

 
 

BOOK FREE TICKETS